Legend Capital

Legend Capital, founded in 2001 as a subsidiary of Legend Holdings Ltd., is a prominent asset manager based in China. With a focus on private equity investments, the firm manages approximately $700 million across four funds and specializes in early-stage and mid-market growth ventures. Its investment strategy primarily targets high-growth companies with significant operations in China or related markets, particularly in sectors such as information technology, consumer goods, clean technology, healthcare, and equipment manufacturing. Legend Capital is known for its active involvement with portfolio companies, providing comprehensive business resources and tailored services to enhance business development and company visibility in the Chinese market. The firm’s portfolio includes notable companies like Joyo.com, SinoCom, and Solarfun Power, reflecting its commitment to driving innovation and value creation within China's venture capital landscape.

Raymond Chen

Co-chief Investment Officer

Arthur Ge

Managing Director

Frank Hong

Managing Director

Richard Li

President

Bibo Peng

VP

Jenking Shao

Managing Director

Piau Voon Wang

Managing Director and Chief Operating Officer

Jafar Wang

Co-CIO / MD

Hank Zhou

Executive Director

Past deals in Series B

Ruicycle

Series B in 2022
Ruicycle is a high-tech company that focuses on the comprehensive recycling and utilization of lithium batteries.

Lipinyun

Series B in 2022
Lipinyun is a tencent strategic investment company. They offer a full-process intelligent sales model, from customer acquisition and screening to customer management and digital asset accumulation, for enterprises diverse sales ecology. Their integration solution helps enterprises realize the upgrade and iteration of digital business.

Qingwei Intelligent Technology

Series B in 2022
Qingwei Intelligent Technology is a Chinese artificial intelligence (AI) chip maker

Medilink Therapeutics

Series B in 2022
MediLink Therapeutics has established its R&D center in Suzhou, China. The company focuses on developing next generation drug conjugates, and aims to serve the vast unmet medical needs in China, and create global value through conducting multicenter clinical trials and cross-border collaborations.

Inceptio Technology

Series B in 2022
Inceptio Technology (Shanghai) Co., Ltd. is an autonomous trucking start-up based in Jiangxi, China, founded in 2018. The company specializes in transforming line-haul logistics through a nationwide freight network that employs autonomous heavy-duty trucks. By leveraging artificial intelligence, new energy technology, and logistics big data, Inceptio Technology aims to enhance the security, efficiency, and cost-effectiveness of transportation services for logistics customers. Its focus on providing transportation-as-a-service positions it to meet the evolving needs of the logistics industry while promoting safer and more efficient freight solutions.

Singlomics

Series B in 2022
Singlomics uses single-cell sequencing technology to develop antibody drugs for the treatment of infectious diseases and cancers.

Beijing Tianxing

Series B in 2022
Beijing Tianxing is a clinical solutions company for sports medicine for implants, arthroscopy devices, and sports medicine equipment.

Xbiome

Series B in 2021
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

ColorTech Bio

Series B in 2021
ColorTech Bio researches and develops precision molecular diagnostic equipment. It offers medical devices to improve biotechnology services and solutions. ColorTech Bio was founded in 2018 and is based in Suzhou, China.

Jifan Biotechnology

Series B in 2021
Jifan Biotechnology is a biotechnology firm that provides molecular biology reagents, diagnostic raw materials, and kits for research.

Wuxi Biortus Biosciences

Series B in 2021
Wuxi Biortus Biosciences Co. Ltd. is a contract research organization that provides research and development services in support of drug discovery. Its services include recombinant protein production; in vitro assays and screening; medicinal chemistry; structural biology; and target validation. The company was founded in 2009 and is based in Jiangyin, China. Wuxi Biortus Biosciences Co. Ltd. operates as a subsidiary of Jiangsu Shuangliang Group Company Ltd.

HC Scientific

Series B in 2021
HC Scientific Technology Co., Ltd. is a company based in Chengdu, China, that specializes in the development, manufacturing, and distribution of genetic testing instruments, reagents, and software. Founded in 2015, the company serves various sectors, including clinical molecular diagnostics, health genetic testing, and agricultural molecular breeding, both domestically and internationally. HC Scientific's product lineup features instruments such as the Matrix Arrayer for reaction plate preparation, the Matrix Cycler for thermal cycling, and the Matrix Scanner for fluorescence detection. Additionally, the company provides consumables like the Matrix plate and Matrix Mix genotyping reagents, along with a data management system known as Matrix Master. Committed to innovation, HC Scientific focuses on autonomous research and development of its intellectual property, aiming to deliver high-throughput, automated, and cost-effective genetic testing solutions.

LYNK Pharmaceuticals

Series B in 2021
LYNK Pharmaceuticals is a biotechnology company based in Hangzhou, China, specializing in the development of small molecule drugs aimed at treating tumors and autoimmune diseases. Founded in 2017, the company focuses on the discovery and development of innovative medicines in the fields of oncology, immunology, and inflammatory diseases. Its business operations include new drug research, sales, and activities related to patent authorization and transfer.

Berry Oncology

Series B in 2021
Berry Oncology develops medical technology intended to improve cancer prevention and tumor diagnosis. It offers genetic diagnosis solutions from early diagnosis to mid-late monitoring that can solve clinical problems in the direction of several malignant tumors, providing patients with a higher quality of life and reduced risk of cancer. The company's mission is early diagnosis and early treatment of all tumors, all patients receive precise treatment. Along with its vision to become a global icon in the field of early screening and early diagnosis of tumors and a leader in China's tumor gene testing market.

Bruco Group

Series B in 2021
Bruco uses innovative technology to create the ultimate product experience and create long-term value for users. The group currently has four core business segments, including Bruker Building Blocks, Bruker Animation, Bubble Education, and Brock Education. Bruco strives to create a whole ecological industry chain with "building blocks +" as the core, and at the same time applies to build blocks to various application scenarios, and lays out a complete T (Toy toy) + A (Animation animation) + G (Game game) +E (Education Education) industry vision.

Fiture

Series B in 2021
Fiture, a fitness technology company, is redefining the home fitness scenarios through intelligent hardware and AI-empowered fitness content.

StoneWise

Series B in 2021
Beijing StoneWise Technology Co., Ltd. operates as a technology company that engages in the research and development (R&D) of artificial intelligence-driven drug design solutions for drug R&D enterprises and institutions. Its drug discovery platform focuses on the investigation and repurpose of nucleoside-based RNA polymerase inhibitors and their potential use in COVID-19 infection treatment. The company was founded in 2018 and is based in Beijing, China.

Sciwind Biosciences

Series B in 2021
Hangzhou Sciwind Biosciences Co., Ltd. develops and sells protein/peptide drugs for treating diseases in multiple therapeutic areas, including diabetes, obesity, metabolic liver diseases, diabetic retinopathy/macular edema, and neuro-degenerative diseases. The company was founded in 2017 and is based in Hangzhou, China.

Exegenesis Bio

Series B in 2021
Exegenesis is going to develop new medicine based on gene therapy and focuses on China and the global market. The team consists of experienced professionals, including gene therapy drug design, preclinical studies and clinical development.

Xbiome

Series B in 2020
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Aqrose Technology

Series B in 2020
Beijing Aqrose Technology Co., Ltd. is a high-tech company specializing in the research and development of computer vision and robotic technology for industrial automation. Founded in 2017, the company is based in Beijing, China, and leverages artificial intelligence to enhance manufacturing processes. Aqrose Technology offers a range of products, including an artificial intelligence deep learning visual inspection platform known as AIDI, which addresses industrial challenges such as defect detection and classification. The company also provides intelligent robots, like AIPICK, equipped with 3D vision technology and AI-based defect inspection systems. With a founding team originating from the Artificial Intelligence Laboratory of Tsinghua University, Aqrose Technology is committed to advancing industrial automation through innovative machine vision and machine learning solutions, thereby empowering advanced manufacturing and smart logistics sectors in China.
Hemu (China) Biological Engineering is a Chinese blood vessel intervention medical equipment firm.

LEADRIVE

Series B in 2020
Leadrive Technology (Shanghai) Co.,Ltd. manufactures homebred power modules and electric vehicle solutions. The company offers products, such as Power Module, Power Control Unit, and Motor. Leadrive Technology (Shanghai) Co.,Ltd. was founded in 2017 and is based in Shanghai, China with additional offices in Shanghai, China; and Aachen, Germany.

Haihe Biopharma

Series B in 2020
HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Uditech

Series B in 2020
Shenzhen Uditech Co., Ltd. develops and manufactures robots for service industry, including restaurants, television, and hospitals. It also manufactures quad core processors. Its robots comprise features, such as face recognition, obstacle avoidance, multi-machine cycle operation, food order and delivery, smart voice, and item transportation. The company was founded in 2013 and is based in Shenzhen, China.

iBeiDiao

Series B in 2020
iBeiDiao is a SaaS background check platform that combines with the Internet.

Wangdiantong

Series B in 2020
Wangdiantong ERP is an enterprise-level e-commerce ERP, supporting Taobao, Tmall, Jingdong, Amazon, Dangdang, No. 1 shop, Alibaba and many other platforms, supporting multi-warehouses, support online stores and physical store cashiers. Including goods management, inventory, orders, purchasing, after-sales, accounts, statistics, CRM and other rich features.

ANYCOLOR

Post in 2020
Ichikara Inc. is an entertainment start-up based in Tokyo, Japan, founded in 2017. The company specializes in creator support and licensing, primarily focusing on the management and operation of virtual streamers associated with the "Nijisanji Project." Ichikara offers a range of services, including access to distribution studios, advertising partnerships, event coordination, and opportunities for program appearances. Additionally, the company actively seeks to discover new talent through auditions, aiming to enhance the virtual entertainment landscape. By leveraging advanced technology, Ichikara strives to create engaging experiences that resonate with audiences globally.

Harbour Biomed

Series B in 2020
Harbour Biomed is a biotechnology company focused on developing bio-therapeutics for immuno-oncology and inflammatory diseases. Established in 2016 and headquartered in Shanghai, with additional operations in Cambridge, Massachusetts, and Rotterdam, the company utilizes two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain-only bispecific antibodies. These platforms facilitate the creation of innovative therapeutic antibodies, enhancing drug discovery and development processes. Harbour Biomed is actively involved in the development of several candidates, including Batoclimab for autoimmune diseases and Tanfanercept for dry eye disease. The company also collaborates with various institutions and partners to license its antibody platforms, further expanding its reach in the biotechnology sector.

Genskey

Series B in 2020
GensKey is a genetic testing medical diagnostic service provider that applies high-throughput sequencing technology to pathogen diagnosis to solve a series of difficulties in the detection rate, timeliness and accuracy of pathogenic diagnosis, so that many patients with severe infections get timely and accurate. Diagnosis.

Nanovision Technology

Series B in 2019
Nanovision Technology is located in Zhongguancun Yongfeng high-tech industrial base, with thousands of square meters of R&D foundation in Yonyou Industrial Park. We also set up a subsidiary company in Chengdu. their company is a high-tech enterprise focused on high-speed and high-precision radiology imaging.Nanovison focus in static CT,x-ray CMOS detectors and x-ray imaging software, etc.Which can be widely used in medical, industrial, security and other fields.

RT-Thread

Series B in 2019
RT-Thread develops an open source real-time operating system for embedded devices. The company offers an autonomous Internet of Things operating system with features, such as cross-chip platform, real-time operating system kernel, cloud integration, ultra-low power design, quick start, security design, intelligent AI engine, and open platform, stable and reliable, rich components, easy to use, and scalable. Its integrated design of the device and cloud enables easy access to all major IoT device cloud platforms. The company’s system also offers functions, such as device virtual file system, device manager framework, low-power management framework, protocol stack, audio streaming framework, firmware remote upgrade FOTA, and third-party components. It serves new energy, electricity, consumption, home appliances, and transportation industries. The company was founded in 2006 and is based in Shanghai, China.

Xbiome

Series B in 2019
Xbiome Co. Ltd. is an AI-based microbiome drug development company founded in 2017 and headquartered in Shenzhen, China. It focuses on intestinal micro-ecology and aims to enhance gut health for a population of 1.3 billion people. By leveraging artificial intelligence, Xbiome analyzes the gut flora of patients and donors, enabling the efficient development of targeted pharmaceuticals for micro-ecological treatment. This innovative approach positions Xbiome as a leader in the application of AI technology within the pharmaceutical industry in China.

Gambol Pet Group

Series B in 2019
Gambol Pet Group Co., Ltd manufacturers pet food. Its Products categories includes: pet treats series which made of chicken jerky, duck jerky, pork, lamb and fish, wet pet food with ingredient of meat and fruits and vegetables, and dog food with nutritional supplements, natural ingredients. It ships products to Europe, Asia, North America. Gambol Pet Group Co., Ltd was founded in 2006 and is headquartered in Liaocheng City, China.

dMed

Series B in 2019
dMed Company Limited, also known as, dMed Biopharmaceutical Co., Ltd. operates as clinical contract research organization providing services for development of medicines and medical devices. The company offer services, including consulting, clinical operations, biostatistics & programming, data management, pharmacovigilance, clinical science & medical affairs, quality assurance, and regulatory affairs & Strategy. It serves biopharmaceutical and medical device companies. dMed Company Limited was founded in 2016 and is based in Shanghai, China.

Mathpresso, Inc.

Series B in 2019
Mathpresso, Inc. is an educational technology company based in Seoul, South Korea, established in 2015. It operates Qanda, a data-driven platform that leverages artificial intelligence and optical character recognition (OCR) technology to assist students with their studies. Users can take a photo of a question or problem, which the platform then analyzes to provide solutions and explanations. Qanda covers a wide range of subjects, including mathematics, Korean history, social studies, and science. The platform is designed to facilitate learning by allowing students to engage with tutors and access answers in real time. As of this year, Qanda has attracted over one million users in South Korea, making it a significant resource for students seeking help with homework and exam preparation.

GalaxySpace

Series B in 2019
GalaxySpace develops and builds LEO broadband satellite constellation, and 5G communication network. The company’s satellite applications include monitoring of airport, parking, and oil reserves, as well as assess land types and uses. GalaxySpace was founded in 2016 and is based in Haidian, China.

AgotoZ

Series B in 2019
AgotoZ Technology provides a network transmission intelligent platform with the capabilities of resource calculation and security defense. Established in 2017, Guanmai Technology (Beijing) Co., Ltd. is a leading WAN high-speed transmission core technology, big data computing technology, security defense technology, and accelerates its core technologies and products through independent research and development, focusing on providing high-speed and efficient enterprises. Interoperability platform and related solutions.

Tongcheng Shenghuo

Series B in 2019
Tongcheng Life is a community O2O group purchase service platform. With the community as a unit, it establishes a community sales office and completes offline delivery. The platform provides supply, logistics, storage and after-sales support. It mainly provides primary edible agricultural products, food, daily necessities, flowers and gardening, and crafts. , Beauty products and other services.

Inossem

Series B in 2019
Nanjing Inossem Software Technology Co., Ltd. provides enterprise application product development and consulting services. The company offers enterprise consulting services that include IT planning, supply chain consulting, ERP consulting, etc. It also focus on material management field of enterprises, and develops intelligent storage (Instock) and intelligent master data (Indata) based on the technical foundation of AI and IoT. The company was founded in 2015 and is based in Nanjing, China. It has additional offices in Canada, the United Kingdom, China, and Hong Kong.

Shuhai Supply Chain

Series B in 2019
Shuhai Supply Chain Logistics is a supply chain service enterprises that provides overall ingredients supply chain solutions services. It has a nationwide modern cold chain logistics center, food processing plants, and other bases. Bohai has been recognized by the industry authorities and customers, has become the benchmark enterprises in the field of supply chain. Founded in June 2011, the company is headquartered in Beijing, China.

Jiangrongxin Technology

Series B in 2019
Developer of financial and marketing software for consumer financial services enterprises. The company's credit card core system helps card issuers manage cardholder's credit and incentives, while their marketing platform can make purchase recommendations to consumers and track user retention.

River Security

Series B in 2019
Silicon Security, founded in 2012, focuses on providing the industry's cutting edge Internet dynamic application security solution. Headquartered in Shanghai, Beijing and Shenzhen, respectively, with branches, and set up a research and development center in Chengdu. Ruimin information after more than two years of research and development, developed a global leader in the leading active defense security technology. The technology completely subvert the traditional continuation of more than 20 years of security technology base, can defend against a variety of unknown modern means of attack, blocking more efficient, more timely, while significantly reducing deployment and use costs.

Black Sesame Technologies

Series B in 2019
Black Sesame Intelligent Technology Co., Ltd. an artificial intelligence company, develops digital imaging technology. The company was founded on July 2016 and is based in China.

Likechuxing

Series B in 2019
Traveling immediately is a car sharing travel service platform taking advantage of the tide of sharing economy. By deep integration of mobile Internet and car time-sharing, it breaks the traditional car travel mode and serves the needs of short-haul travel within the city. Travel APP immediately combines the depth of the mobile Internet with the time-sharing of cars. The user can realize the intelligent operation of the whole process of the car at any time through the APP, and only need to bear the mileage and long-term cost. “Travel immediately” changed the way traditional car trips and car rentals.

Harbour Biomed

Series B in 2018
Harbour Biomed is a biotechnology company focused on developing bio-therapeutics for immuno-oncology and inflammatory diseases. Established in 2016 and headquartered in Shanghai, with additional operations in Cambridge, Massachusetts, and Rotterdam, the company utilizes two patented transgenic mouse platforms for generating fully human monoclonal antibodies and heavy chain-only bispecific antibodies. These platforms facilitate the creation of innovative therapeutic antibodies, enhancing drug discovery and development processes. Harbour Biomed is actively involved in the development of several candidates, including Batoclimab for autoimmune diseases and Tanfanercept for dry eye disease. The company also collaborates with various institutions and partners to license its antibody platforms, further expanding its reach in the biotechnology sector.

Urotronic

Series B in 2018
Urotronic, Inc. is a medical device company based in Plymouth, Minnesota, founded in 2014. The company specializes in developing innovative solutions for urology, particularly in the treatment of urethral blockages. Its flagship product, Optilume, is a drug-coated balloon catheter designed to treat urethral strictures in men. This device combines balloon dilation with localized drug delivery, utilizing the drug paclitaxel to inhibit cell proliferation and reduce the formation of scar tissue that can lead to stricture recurrence. By effectively covering the affected area during the procedure, Optilume offers a low-cost, minimally-invasive treatment option for patients suffering from urinary tract conditions, catering primarily to urologists and their patients.

Spacety

Series B in 2018
Spacety is a microsatellite start-up that specializes in developing commercial micro/nano-satellites. It provides short-cycle, low-cost, and one-stop services to scientists, research institutes, and commercial companies, for science experiments and technology demonstrations. At present, the company has launched four commercial microsatellites and aims for more in the future. The company was founded in January 2016 with headquarters in Changsha, China.

Lunit

Series B in 2018
Lunit Inc. is a South Korean company that specializes in developing advanced algorithms for medical image analysis and general object detection using machine learning technology. The firm focuses on areas such as digital chest X-ray, digital mammography, digital pathology, and fundus photography. By leveraging cutting-edge deep learning techniques, Lunit aims to assist physicians in making accurate and efficient clinical decisions. The company has demonstrated its expertise in image recognition, having ranked among the top five in the ImageNet Challenge, a prominent competition in the field. Lunit's technology is notable for its ability to utilize weakly labeled data, enhancing its pattern recognition capabilities. Supported by significant venture capital investments, Lunit is actively engaged in large-scale research collaborations with major university hospitals in South Korea, reflecting its strong reception within the medical community.

Aikucun

Series B in 2018
Aikucun is a sales distribution company that provides fast and controllable inventory sales channels. As the micro-business purchasing channels have a certain privacy, completely independent of the traditional sales channels, and will not affect the brand's existing sales system. The brand owner can easily complete the inventory sales simply by sharing the inventory. Founded in 2017 by Shanghai Zhongdan Information Technology Co., Ltd., Aikucun is a crowdsourcing distribution platform.

Paixue Che

Series B in 2018
Pai Xueche is an Internet driving training platform. The school adopts a consultant tracking system throughout the process. The company will equip each student with an exclusive learning car consultant, from registration to the student's driver's license, the whole process of tracking.

Enjoy Dental Clinic

Series B in 2018
Enjoy Dental Clinic provides dental care services. The company was founded in 2007 and is based in Beijing, China.

Nattitude

Series B in 2018
An E-commerce Platform based in Guangzhou,China.

Uditech

Series B in 2018
Shenzhen Uditech Co., Ltd. develops and manufactures robots for service industry, including restaurants, television, and hospitals. It also manufactures quad core processors. Its robots comprise features, such as face recognition, obstacle avoidance, multi-machine cycle operation, food order and delivery, smart voice, and item transportation. The company was founded in 2013 and is based in Shenzhen, China.

Deepwise

Series B in 2018
Shenzhen Rui Medica is an artificial intelligence technology-based clinical imaging services provider. The company focuses on the development of clinical imaging diagnosis system for early-stage detection of cancer. Its services covers breast cancer, prostate cancer, and chest radiograph.

INXX

Series B in 2018
Hangzhou INXX Fashion Co,. Ltd. retails apparels and accessories through the Internet. The company is based in Hangzhou, China.

Kunya Medical

Series B in 2018
Shanghai Kunya Medical Co., Ltd is a medical equipment service platform established in 2009 and headquartered in Shanghai, China. The company specializes in the maintenance and servicing of imaging and radiation equipment for hospitals. Its primary offerings include hosting services for hospital imaging and radiation equipment departments, as well as comprehensive management of medical equipment. Kunya Medical provides technical support for both domestic and international brands of large and medium-sized medical devices, which encompasses maintenance, equipment relocation, installation, and debugging services. Additionally, the company supplies a wide range of spare parts and equipment management software, positioning itself as a key player in the medical equipment service industry.

iPayLinks

Series B in 2018
iPayLinks Financial Information Service (Shanghai) Co., Ltd., headquartered in Shanghai, China, is a prominent provider of cross-border settlement services. The company has established branches in multiple locations, including Shenzhen, Hong Kong, Singapore, Malaysia, the UK, the US, the UAE, and India, serving over 50,000 institutions and enterprises. iPayLinks offers a comprehensive "three-in-one" cross-border settlement solution tailored for e-commerce and travel sectors, facilitating payments through various international credit cards and localized payment methods across more than 200 regions. Their platform also enables collection services from major online marketplaces such as Amazon and eBay, alongside a one-stop collection and distribution system. Additionally, iPayLinks provides supply chain finance products to enhance working capital efficiency. The company holds several international licenses and has achieved PCI-DSS Level-1 certification, underscoring its commitment to security in payment services. iPayLinks has garnered recognition, including awards from KPMG and Deloitte, and has received funding from notable investors like Tencent and Legend Capital.

Hongliyu Cinema

Series B in 2018
Hongliyu Cinema is a Chinese rural cinema operator. It focuses on film and television production and advertising operation services, and professional support in China.

Taihe Music Group

Series B in 2017
Taihe Music Group is a global music service provider and record label producer that provides artist services, copyright management, audio-visual services and live performance.

Yanwen Express

Series B in 2017
Beijing Yanwen Logistics Co., Ltd, founded in 1998 and based in Beijing, China, specializes in freight forwarding and logistics services tailored to the needs of various customers, particularly in the e-commerce sector. The company offers a range of customized solutions, facilitating the shipment of items from small packages to larger goods through diverse transportation methods, including aircraft, trains, and automobiles. Yanwen Logistics is dedicated to providing professional transport management to ensure efficient and reliable delivery services. The company's operations are supported by the relevant governmental approvals, allowing it to meet the logistics demands of a wide array of clients.

Immunochina

Series B in 2017
ImmunoChina Pharmaceuticals manufactures medical products. The Company produces cell injections, cell therapy drugs, and other products. ImmunoChina Pharmaceuticals also provides medical technology development, medical research, medical trial development, and other services.

Weshine

Series B in 2017
WeShine is a Chinese platform specializing in the sharing of GIF images and video content. The service has reached over 800 million users across China, establishing a significant presence in the market with a reported market share of over 90% in the GIF search engine sector. WeShine offers a user-friendly interface that enables individuals to easily search for and share popular visual content, making it a prominent player in the digital media landscape.

Bellen

Series B in 2017
Bellen Chemistry Co., Ltd. is a medical contract research organization based in Beijing, China, founded in 2007. The company specializes in the development of chemical synthesis for pharmaceutical applications, focusing on the design and creation of heterocycles and novel molecules. Bellen offers a range of services including discovery chemistry, process development, and active pharmaceutical ingredient (API) manufacturing on a commercial scale. It serves clients in the chemical, pharmaceutical, and biotechnology sectors, supported by a robust research and development team of over 200 scientists. Bellen maintains a research lab in Beijing, a research center in Shanghai, and a manufacturing facility in Shandong province, along with offices in the United States, the United Kingdom, France, Canada, and Japan.

Ucpaas

Series B in 2017
Shenzhen City, the Network Technology Co., Ltd. (hereinafter referred to as the cloud of the News), is a commitment to create an open platform for converged communications services for the majority of developers to provide low-threshold efficient communication service provider entrepreneurial opportunities. News converged communication open cloud platform is a cloud of Shenzhen's Network Technology Co., Ltd. for the Internet, mobile Internet, the majority of developers and businesses to provide communication capabilities PaaS cloud computing platform. Platform integration of the three operators and Internet IP network, through the clouds open Rest API and client SDK (Android, IOS, Windows SDK) way communications capabilities available to developers and businesses, so that companies and developers to easily build voice , SMS, VOIP, video and other solutions, no hardware, network costs, quickly set up and use of carrier-grade communications capabilities. News cloud VoIP communications industry has 10 years of operating the accumulation of successful operation, the development of a total of over 200 million registered users of the product, assembled VoIP industry for more than 70 percent of telecommunications resources. The company has a number of the pursuit of "innovation, speed, perfect" specialized Internet operations team, whose core members are from traditional telecommunications, the Internet industry, well-known IT companies, an average of more than 10 years of experience, with deep product development capability and operational service experience, the communication, the Internet industry has a profound understanding, with strong technology and model innovation capability.

New Horizon Health

Series B in 2017
New Horizon Health, founded in 2015 and headquartered in Hangzhou, China, specializes in developing advanced technologies for the detection and screening of gastrointestinal cancers, particularly gastric and colorectal cancers. The company offers innovative products based on fecal gene analysis (FIT-DNA) technology, enabling users to conduct at-home tests that identify signs of colon cancer and significant adenomas. This technology facilitates earlier detection of precancerous lesions compared to conventional blood tests. By leveraging big data and artificial intelligence, New Horizon Health enhances its cancer screening solutions, aiming to improve public health outcomes. The company also emphasizes its commitment to making early cancer screening accessible to households, thereby striving to reduce the incidence and mortality associated with cancer.

Akulaku

Series B in 2017
Akulaku Inc. is a consumer finance platform based in Jakarta, Indonesia, established in 2016. The company specializes in offering online financial credit services to customers across Southeast Asia. Its services include shopping in installments through an independently managed online marketplace and various other platforms, as well as providing flexible cash loans. Akulaku's mission is to enhance the quality of life for both partners and consumers by creating a comprehensive and reliable financial ecosystem.

PhiSkin

Series B in 2017
PhiSkin is a skin and laser clinic located in China, specializing in a range of skin care treatments. The clinic offers services that utilize advanced laser technology and skin care techniques to address various skin concerns. By focusing on effective and innovative solutions, PhiSkin aims to enhance the overall skin health and appearance of its clients.

Jianshu

Series B in 2017
Jianshu Group (Cayman) Limited operates a user-generated content (UGC) publishing platform that caters to both personal computer and mobile users. Based in China, Jianshu enables individuals to create, publish, and share mid to long-form content, which can include articles, images, and videos. The platform supports bilingual publication, allowing users to write and read content in both Chinese and English. By fostering a community for sharing diverse content, Jianshu facilitates engagement across Chinese and Western social networks.
Qiang Sen International Community Medical (QSICM) operates community healthcare service centers. The Clinic offers internal medicine, pediatrics, gynecology, stomatology, laboratory, ultrasonography, and electrocardiography services. QSICM serves patients in China.

POCTech Corporation

Series B in 2017
Zhejiang POCTech Co.,Ltd. engages in the research, development, manufacture, marketing, and service of POCT systems for diabetes management. Its products include CT-100 continuous glucose monitoring systems, a 0.3 mm soft sensor and implants to abdomen and arms; and ST-100 handheld blood gas and electrolyte analyzers, a handheld POCT instrument for use in medical fields such as clinics, ambulances, wards, and other point-of-care occasions. Additionally the company also manufactures MT-300 and SP-101 glucose analyzers for real-time blood glucose measurement. Zhejiang POCTech Co.,Ltd. was founded in 2010 and is headquartered in Huzhou, China.

Suzhou Ribo Life Science

Series B in 2017
Suzhou Ribo Life Science is a developer of RNA interference ( RNAi ) technology designed to treat liver diseases. The company's RNA interference ( RNAi ) technology is used to develop nucleic acid therapeutic drugs and related products, enabling healthcare providers to deliver more effective pharmaceuticals to patients.

Zongmu

Series B in 2017
ZongMu Technology was founded in January 2013. Headquartered in Pudong ZhangJiang high-tech park of Shanghai, ZongMu has RD centers in Beijing and ShenZhen respectively. Through its innovative solution and excellent service to the local market, ZongMu has shipped multiple SurroundView ADAS (Advanced Driving Assistance System) in main stream OEM automotive markets, becoming the leading SurroundView ADAS solution vendor for China domestic market and formed strategic partnership with multiple OEM car makers and their tier1 suppliers.

Tangdou

Series B in 2016
Tangdou is a Chinese Senior Citizen Dance Video FirmTangdou Guangchangwu conducts dance lessons. The firm is headquartered in China..

Zuoyebang

Series B in 2016
Zuoyebang currently cooperates with 113 educational organizations and 370,000 primary schools and high schools in China. Zuoyebang, which started as a phase of Q&A website Baidu Zhidao, is a platform where scholars can seek answers to study-related problems, and also supply method to peers who are trying to find assistance.

Yujia

Series B in 2016
Shenzhen Yujia Entertainment Media Co., Ltd. operates as a Web agency offering talent screening services for entertainment industry. The company is based in China.

UNIMED

Series B in 2016
Tongxin Yilian Technology (Beijing) Co., Ltd. develops online medical treatment system, Unimed. The company is based in Beijing, China.

Udesk

Series B in 2016
Udesk Ltd. operates as a customer experience solution provider The company omnichannel communication, a platform that integrates call center, online customer service, and work order system, connects different communication channels, and connects global customers; text conversation robot, voice robot, agent assistant, and quality inspection; cover multiple application scenarios, deployment of multiple solutions, and security architecture; sales cloud, field service cloud, customer service and complaint management system, and business intelligence analysis. It serves to health, Internet, hotel, retail, logistics, manufacturing, real estate, legal, education, automobile, insurance, and banking industry. The company was founded in 2014 and is based in Beijing, China.

DBSec

Series B in 2016
DBSec is an Enterprise services company.

SNH48

Series B in 2016
SNH48 is a Chinese idol girl group based in Shanghai, China. Following AKB48's creator Yasushi Akimoto's concept of "idols you can meet", the group features dozens of female members around the age of 20, who perform regularly in the group's own theater and interact with fans predominantly via handshake events.[2] The group is owned by Chinese companies NineStyle and Star48.[3]

Jollychic

Series B in 2016
Jollychic EC Limited is an online retail platform that offers a diverse range of products, including clothing, shoes, bags, baby items, electronics, home goods, and various accessories. Established in 2012 and headquartered in Birkirkara, Malta, Jollychic aims to provide customers with a convenient shopping experience through its extensive selection of stylish and quality products. The platform features categories such as apparel, sports goods, toys, bedding, wedding supplies, cleaning tools, and kitchen appliances, making it a comprehensive destination for consumers seeking a variety of goods in one place.
Shanghai Cell Therapy Group Co., Ltd., established in 2013 and headquartered in Shanghai, China, specializes in the field of cell therapy technology. The company provides technical services and consulting, as well as technology transfer and investments within the healthcare sector. It operates a cellular diagnosis center that integrates cellular research and treatment services, focusing on areas such as cellular cold storage and cellular pharmaceuticals. Additionally, Shanghai Cell Therapy Group facilitates genetic testing for patients and supports cancer facilities by supplying essential research data.
Axonics is a pre-revenue company developing novel implantable neuromodulation technology licensed from The Alfred Mann Foundation directed toward a number of clinical indications, including the treatment of chronic pain and overactive bladder.

Noitom

Series B in 2015
Beijing Noitom Technology Limited specializes in sensor-based motion capture systems, catering to various industries including visual effects, animation, virtual reality, gaming, sports and fitness, health, education, and simulation. Founded in 2010 by a team of engineers and scientists, including experts in mechanics, software, robotics, and sensor engineering, Noitom aims to redefine the motion capture landscape. The company's research and development efforts focus on accurately mapping human body movements and interactions with the environment. The name "Noitom," which is "motion" spelled backward, reflects the company's commitment to the art of motion capture. Based in Beijing, China, Noitom continues to innovate within its field, providing solutions for both original equipment manufacturers and original design manufacturers.

ET Healthcare

Series B in 2015
ET Healthcare, Inc. is an in vitro diagnostics company that specializes in manufacturing central laboratory analyzers for both inpatient and outpatient testing in various medical settings, including hospitals and clinics. The company has developed the Pylon Immunochemistry System, an integrated turnkey solution that addresses the immunodiagnostics needs across several areas, such as inflammation, cardiac function, fertility, infectious diseases, and tumors. Additionally, the Pylon BNP Immunoassay aids in managing heart failure by measuring B-type natriuretic peptide levels in plasma. ET Healthcare’s offerings include a variety of immunoassays for cardiac markers, blood clots, and other health conditions, facilitating simplified blood analysis for physicians. Based in Palo Alto, California, the company also has offices in Shanghai, China, and operates manufacturing facilities in Suzhou, China.

Ruhnn

Series B in 2015
Ruhnn Holding Limited, together with its subsidiaries, operates key opinion leader (KOL) cultivation and incubation platforms in the People's Republic of China. The company engages in the sale of various fashion and lifestyle products to consumers through its KOL online stores; and provision of various KOL sales and advertising services to third-party merchants. Its online stores primarily provide women's apparel, cosmetics, shoes, and handbags. As of March 31, 2020, it owned and operated 19 online stores; and had 168 signed KOLs. The company was founded in 2016 and is headquartered in Hangzhou, the People's Republic of China.

UCAR

Series B in 2015
UCAR, established in 1999 and headquartered in Tianjin, China, is a leading provider of chauffeured car services in the country. The company operates an on-demand car-hailing platform that connects customers with local drivers through mobile technology. UCAR offers both chauffeured car services and vehicle rentals, utilizing an in-house fleet alongside licensed local drivers. The company's commitment to safety and quality is evident in its rigorous driver background checks, vehicle condition monitoring, and the use of advanced technologies to track driver behavior. UCAR also emphasizes customer privacy and provides quick compensation for accidents, ensuring a reliable and secure experience for users.